AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-5328309_ITM" title="Facts and information about Tumor vaccine therapy reviewed.">Tumor vaccine therapy reviewed.</a>

Close Set up an RSS feed that alerts you when new articles from Clinical Oncology Week are available.

Frequently asked questions about RSS feeds

Tumor vaccine therapy reviewed.

Clinical Oncology Week

| December 06, 2004 | COPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers review tumor vaccine therapy in a recent issue of Blood.

According to published research from the United States, "Fusion proteins containing chemokine receptor ligands have been used to selectively deliver tumor antigens to the MHC class II processing pathway in dendritic cells, promoting tumor-specific CD4 T-cell responses and tumor-specific immunity,"

"This novel strategy of vaccination, targeting the antigen-presenting cell (APC), may have broad application to T-cell immunotherapy," wrote Scott S. Zamvil and Thomas Prod'homme at the University of California-San Francisco.

Zamvil and Prod'homme …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Researchers report results of the San Francisco Bay area breast cancer study.: Newspaper article from: Clinical Oncology Week January 26, 2004 700+ words
...cancer registry in the San Francisco Bay area, and a random...multiethnic population: The San Francisco Bay area breast cancer...prepared by Clinical Oncology Week editors from staff...Copyright 2004, Clinical Oncology Week via NewsRx.com...


New protein associated with aggressiveness in breast and ovarian cancer.: Newspaper article from: Clinical Oncology Week November 22, 2004 700+ words
...University of California San Francisco, and Northwestern...University of California San Francisco. This article was prepared by Clinical Oncology Week editors from staff...Copyright 2004, Clinical Oncology Week via NewsRx.com...


Geographic differences influence prostate cancer mortality rates.: Newspaper article from: Clinical Oncology Week May 31, 2004 700+ words
...Urological Association's 99th Annual Scientific Meeting, held in San Francisco. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2004, Clinical Oncology Week via NewsRx.com & NewsRx.net.


Hysterectomy-alternative to treat uterine fibroids offered by California OBGYN.: Newspaper article from: Clinical Oncology Week December 20, 2004 700+ words
...Laproscopists, and at the Global Congress of Gynecologic Endoscopy in San Francisco. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2004, Clinical Oncology Week via NewsRx.com & NewsRx.net.


U.S. FDA approves new drug for the most common type of lung cancer.: Newspaper article from: Clinical Oncology Week December 20, 2004 700+ words
...and distributed by Genentech, Inc., of South San Francisco, California. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2004, Clinical Oncology Week via NewsRx.com & NewsRx.net.


Biosciences company adds member to scientific advisory board.: Newspaper article from: Clinical Oncology Week November 15, 2004 700+ words
...biopharmaceutical company headquartered in South San Francisco, California. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2004, Clinical Oncology Week via NewsRx.com & NewsRx.net.


Patent dispute over Neupogen settled.: Newspaper article from: Clinical Oncology Week September 15, 2003 700+ words
...share. Amgen, based in Thousand Oaks, California, is the world's largest biotechnology company, followed by South San Francisco-based Genentech. This article was prepared by Clinical Oncology Week editors from staff and other reports.


Embryonic pathway critical to growth of digestive tract tumors.: Newspaper article from: Clinical Oncology Week November 10, 2003 700+ words
...cancer and written by researchers at the University of California at San Francisco and Harvard Medical School, appears in the same issue of the journal. This article was prepared by Clinical Oncology Week editors from staff and other reports.


Liposome-based approaches can target drugs to tumor tissue.: Newspaper article from: Clinical Oncology Week February 9, 2004 700+ words
...University of California, San Francisco, Division of Hematology...University of California, San Francisco, Division of Hematology...2340 Sutter St., San Francisco, CA 94115, USA...prepared by Clinical Oncology Week editors from staff...


Cryotherapy may play a bigger role in future treatment of prostate cancer.: Newspaper article from: Clinical Oncology Week February 16, 2004 700+ words
...University of California, San Francisco, Department of Urology...University of California San Francisco, Department Urology...Divisadero St. A634, San Francisco, CA 94143, USA...prepared by Clinical Oncology Week editors from staff...

For more facts and information, see all results

Source: HighBeam Research, Tumor vaccine therapy reviewed.

The AccessMyLibrary advertising network includes: